Legal & General Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Legal & General Group’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,180	Closed	-$47K	–	2898
2016 Q2	$47K	Hold	3,180	–	–	﹤0.01%	2508
2016 Q1	$38K	Hold	3,180	–	–	﹤0.01%	2529
2015 Q4	$50K	Hold	3,180	–	–	﹤0.01%	2465
2015 Q3	$49K	Hold	3,180	–	–	﹤0.01%	2468
2015 Q2	$76K	Hold	3,180	–	–	﹤0.01%	2321
2015 Q1	$74K	Hold	3,180	–	–	﹤0.01%	2250
2014 Q4	$82K	Hold	3,180	–	–	﹤0.01%	2120
2014 Q3	$97K	Buy	+3,180	New	+$86.1K	﹤0.01%	1904

Legal & General Group's SGNT Position: Q3 2016 in Review

Legal & General Group sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 3,180 shares — an estimated $47K sold.

Legal & General Group first reported a position in SGNT in Q3 2014 and held it in 8 quarters. The position peaked at $97K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Legal & General Group reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Legal & General Group sold 3,180 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $47K.
Legal & General Group first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 8 quarters.
Legal & General Group's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $97K in Q3 2014.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Legal & General Group's 13F filing for Q3 2016, filed 12 Oct 2016.